Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC AMXI-5001 hydrochloride | 00-00-0 | 98.1% | C25H21ClFN5O3 | 10MG
SDP

Supplier:  Medchemexpress LLC HY145734A10MG

Encompass_Preferred

AMXI-5001 hydrochloride is a research-grade small molecule described as a dual inhibitor of PARP1/2 and microtubule polymerization. It shows potent cellular activity against PARP and tubulin targets, with reported favorable metabolic stability and oral bioavailability, and is intended for preclinical anticancer research.

  • Dual mechanism: inhibits PARP1/2 and tubulin polymerization.
  • Potent PARP inhibition with low nanomolar IC50s and tubulin inhibition in the micromolar range.
  • Orally bioavailable with favorable pharmacokinetic properties.
  • Suitable for in vitro and in vivo anticancer studies.
  • High purity for research applications.

Catalog No. 50-002-58751


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.